Reported a net loss of $3.2 million for the three months ended March 31, 2026, compared to a $4.4 million loss in the same period of 2025. Operating expenses decreased to $4.1 million from $5.0 million in the prior year period. Cash, cash equivalents, and restricted cash totaled $15.6 million as of March 31, 2026. The company anticipates sufficient funding to support operations into the first quarter of 2027. Authorized common stock was increased from 30 million to 130 million shares following shareholder approval on May 1, 2026.